XGN - Exagen expands coverage for its AVISE tests with MediNcrease provider network

Exagen (NASDAQ:XGN) on Thursday said it had been added to MediNcrease Health Plans' national provider network. XGN said the addition will expand the coverage of the company's products to MediNcrease Health Plans' about 7.5M members. The agreement is effective July 1. As per the agreement, MediNcrease will make Exagen's AVISE diagnostic tests accessible through its client base. St. Petersburg, Fla.-based MediNcrease Health Plans is a national, directly-contracted provider of solutions to reduce medical expenditures. It operates in commercial health, auto medical and worker's compensation insurance markets. XGN stock -4.3% to $5.77 in morning trade following a 1.2% loss in the previous session. It had ended nearly 19% higher on June 7.

For further details see:

Exagen expands coverage for its AVISE tests with MediNcrease provider network